BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17498647)

  • 1. Regulation of intestinal hPepT1 (SLC15A1) activity by phosphodiesterase inhibitors is via inhibition of NHE3 (SLC9A3).
    Anderson CM; Thwaites DT
    Biochim Biophys Acta; 2007 Jul; 1768(7):1822-9. PubMed ID: 17498647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indirect regulation of the intestinal H+-coupled amino acid transporter hPAT1 (SLC36A1).
    Anderson CM; Thwaites DT
    J Cell Physiol; 2005 Aug; 204(2):604-13. PubMed ID: 15754324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal absorptive transport of the dipeptide glycylsarcosine is dependent on functional Na+/H+ exchange activity.
    Kennedy DJ; Leibach FH; Ganapathy V; Thwaites DT
    Pflugers Arch; 2002 Oct; 445(1):139-46. PubMed ID: 12397398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of intestinal dipeptide transport by the neuropeptide VIP is an anti-absorptive effect via the VPAC1 receptor in a human enterocyte-like cell line (Caco-2).
    Anderson CM; Mendoza ME; Kennedy DJ; Raldua D; Thwaites DT
    Br J Pharmacol; 2003 Feb; 138(4):564-73. PubMed ID: 12598410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. H/dipeptide absorption across the human intestinal epithelium is controlled indirectly via a functional Na/H exchanger.
    Thwaites DT; Kennedy DJ; Raldua D; Anderson CM; Mendoza ME; Bladen CL; Simmons NL
    Gastroenterology; 2002 May; 122(5):1322-33. PubMed ID: 11984519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The proton-coupled amino acid transporter, SLC36A1 (hPAT1), transports Gly-Gly, Gly-Sar and other Gly-Gly mimetics.
    Frølund S; Holm R; Brodin B; Nielsen CU
    Br J Pharmacol; 2010 Oct; 161(3):589-600. PubMed ID: 20880398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual modes of 5-(N-ethyl-N-isopropyl)amiloride modulation of apical dipeptide uptake in the human small intestinal epithelial cell line Caco-2.
    Kennedy DJ; Raldua D; Thwaites DT
    Cell Mol Life Sci; 2005 Jul; 62(14):1621-31. PubMed ID: 15968466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The apical (hPepT1) and basolateral peptide transport systems of Caco-2 cells are regulated by AMP-activated protein kinase.
    Pieri M; Christian HC; Wilkins RJ; Boyd CA; Meredith D
    Am J Physiol Gastrointest Liver Physiol; 2010 Jul; 299(1):G136-43. PubMed ID: 20430871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vigabatrin transport across the human intestinal epithelial (Caco-2) brush-border membrane is via the H+ -coupled amino-acid transporter hPAT1.
    Abbot EL; Grenade DS; Kennedy DJ; Gatfield KM; Thwaites DT
    Br J Pharmacol; 2006 Feb; 147(3):298-306. PubMed ID: 16331283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. H+-coupled nutrient, micronutrient and drug transporters in the mammalian small intestine.
    Thwaites DT; Anderson CM
    Exp Physiol; 2007 Jul; 92(4):603-19. PubMed ID: 17468205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delta-aminolevulinic acid is a substrate for the amino acid transporter SLC36A1 (hPAT1).
    Frølund S; Marquez OC; Larsen M; Brodin B; Nielsen CU
    Br J Pharmacol; 2010 Mar; 159(6):1339-53. PubMed ID: 20128809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The absorptive flux of the anti-epileptic drug substance vigabatrin is carrier-mediated across Caco-2 cell monolayers.
    Nøhr MK; Hansen SH; Brodin B; Holm R; Nielsen CU
    Eur J Pharm Sci; 2014 Jan; 51():1-10. PubMed ID: 24008184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sertraline inhibits the transport of PAT1 substrates in vivo and in vitro.
    Nielsen CU; Frølund S; Abdulhadi S; Sari H; Langthaler L; Nøhr MK; Kall MA; Brodin B; Holm R
    Br J Pharmacol; 2013 Nov; 170(5):1041-52. PubMed ID: 23962042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Function and immunolocalization of overexpressed human intestinal H+/peptide cotransporter in adenovirus-transduced Caco-2 cells.
    Hsu CP; Walter E; Merkle HP; Rothen-Rutishauser B; Wunderli-Allenspach H; Hilfinger JM; Amidon GL
    AAPS PharmSci; 1999; 1(3):E12. PubMed ID: 11741208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal drug transport via the proton-coupled amino acid transporter PAT1 (SLC36A1) is inhibited by Gly-X(aa) dipeptides.
    Frølund S; Langthaler L; Kall MA; Holm R; Nielsen CU
    Mol Pharm; 2012 Sep; 9(9):2761-9. PubMed ID: 22853447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. H+/amino acid transporter 1 (PAT1) is the imino acid carrier: An intestinal nutrient/drug transporter in human and rat.
    Anderson CM; Grenade DS; Boll M; Foltz M; Wake KA; Kennedy DJ; Munck LK; Miyauchi S; Taylor PM; Campbell FC; Munck BG; Daniel H; Ganapathy V; Thwaites DT
    Gastroenterology; 2004 Nov; 127(5):1410-22. PubMed ID: 15521011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ibuprofen is a non-competitive inhibitor of the peptide transporter hPEPT1 (SLC15A1): possible interactions between hPEPT1 substrates and ibuprofen.
    Omkvist DH; Brodin B; Nielsen CU
    Br J Pharmacol; 2010 Dec; 161(8):1793-805. PubMed ID: 20726987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carrier-mediated γ-aminobutyric acid transport across the basolateral membrane of human intestinal Caco-2 cell monolayers.
    Nielsen CU; Carstensen M; Brodin B
    Eur J Pharm Biopharm; 2012 Jun; 81(2):458-62. PubMed ID: 22452873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of a nonpeptidic drug, valacyclovir, with the human intestinal peptide transporter (hPEPT1) expressed in a mammalian cell line.
    Guo A; Hu P; Balimane PV; Leibach FH; Sinko PJ
    J Pharmacol Exp Ther; 1999 Apr; 289(1):448-54. PubMed ID: 10087037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basolateral glycylsarcosine (Gly-Sar) transport in Caco-2 cell monolayers is pH dependent.
    Berthelsen R; Nielsen CU; Brodin B
    J Pharm Pharmacol; 2013 Jul; 65(7):970-9. PubMed ID: 23738724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.